Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Breast Cancer

  Free Subscription


1 Ann Oncol
1 Ann Surg
4 Ann Surg Oncol
1 Anticancer Res
1 BMC Cancer
1 Br J Cancer
1 Breast Cancer (Auckl)
3 Breast Cancer Res
14 Breast Cancer Res Treat
2 Breast J
4 Cancer
1 Cancer Lett
1 Cancer Res
1 Carcinogenesis
1 Clin Breast Cancer
1 Clin Cancer Res
1 Eur J Cancer
1 Exp Cell Res
1 Int J Radiat Oncol Biol Phys
2 J Clin Oncol
2 J Surg Oncol
1 Lancet Oncol
1 Nat Rev Cancer
1 Nature
2 Oncogene
1 Oncology
3 PLoS One
1 Radiology
6 Semin Oncol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Oncol

  1. DI COSIMO S, Appierto V, Silvestri M, Ortolan E, et al
    Primary tumor somatic mutations in the blood of women with ductal carcinoma in situ of the breast.
    Ann Oncol. 2020;31:435-437.

    Ann Surg

  2. HWANG RF, Hunt KK
    The Emergence of Robotic-assisted Breast Surgery: Proceed With Caution.
    Ann Surg. 2020;271:1013-1015.

    Ann Surg Oncol

  3. MONTAGNA G, Morrow M
    ASO Author Reflections: Axillary Staging in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy-Beyond Clinical Trials.
    Ann Surg Oncol. 2020 Jun 4. pii: 10.1245/s10434-020-08693.

  4. TAMBURELLI F, Ponzone R
    The Value of Repeated Breast Surgery as a Quality Indicator in Breast Cancer Care.
    Ann Surg Oncol. 2020 Jun 10. pii: 10.1245/s10434-020-08704.
    PubMed         Abstract available

    ASO Author Reflections: The Difficult Assessment of the Hard-Won Progress of Breast Cancer Care.
    Ann Surg Oncol. 2020 Jun 8. pii: 10.1245/s10434-020-08719.

  6. ALVARADO MD, Mittendorf EA, Teshome M, Thompson AM, et al
    Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer.
    Ann Surg Oncol. 2020 Jun 8. pii: 10.1245/s10434-020-08688.
    PubMed         Abstract available

    Anticancer Res

  7. SCHMIDT-WOLF R, Zissel G
    Interaction Between CCL18 and GPR30 Differs from the Interaction Between Estradiol and GPR30.
    Anticancer Res. 2020;40:3097-3108.
    PubMed         Abstract available

    BMC Cancer

  8. HAGERLING C, Owyong M, Sitarama V, Wang CY, et al
    LGR5 in breast cancer and ductal carcinoma in situ: a diagnostic and prognostic biomarker and a therapeutic target.
    BMC Cancer. 2020;20:542.
    PubMed         Abstract available

    Br J Cancer

  9. YUAN WH, Hsu HC, Chen YY, Wu CH, et al
    Supplemental breast cancer-screening ultrasonography in women with dense breasts: a systematic review and meta-analysis.
    Br J Cancer. 2020 Jun 12. pii: 10.1038/s41416-020-0928.
    PubMed         Abstract available

    Breast Cancer (Auckl)

  10. AL-MOUSA DS, Alakhras M, Spuur KM, Alewaidat H, et al
    Mammographic Breast Density Profile of Jordanian Women With Normal and Breast Cancer Findings.
    Breast Cancer (Auckl). 2020;14:1178223420921381.
    PubMed         Abstract available

    Breast Cancer Res

  11. YIN L, Duan JJ, Bian XW, Yu SC, et al
    Triple-negative breast cancer molecular subtyping and treatment progress.
    Breast Cancer Res. 2020;22:61.
    PubMed         Abstract available

  12. HUMPHRIES BA, Cutter AC, Buschhaus JM, Chen YC, et al
    Enhanced mitochondrial fission suppresses signaling and metastasis in triple-negative breast cancer.
    Breast Cancer Res. 2020;22:60.
    PubMed         Abstract available

  13. BAKER LA, Holliday H, Roden D, Krisp C, et al
    Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer.
    Breast Cancer Res. 2020;22:63.
    PubMed         Abstract available

    Breast Cancer Res Treat

  14. HEEG E, Jensen MB, Mureau MAM, Ejlertsen B, et al
    Breast-contour preserving procedures for early-stage breast cancer: a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands.
    Breast Cancer Res Treat. 2020 Jun 10. pii: 10.1007/s10549-020-05725.
    PubMed         Abstract available

  15. ALTHOBITI M, Muftah AA, Aleskandarany MA, Joseph C, et al
    The prognostic significance of BMI1 expression in invasive breast cancer is dependent on its molecular subtypes.
    Breast Cancer Res Treat. 2020 Jun 10. pii: 10.1007/s10549-020-05719.
    PubMed         Abstract available

    Breast cancer care during a pandemic: an opportune time for cryoablation?
    Breast Cancer Res Treat. 2020 Jun 11. pii: 10.1007/s10549-020-05724.
    PubMed         Abstract available

  17. RO EJ, Ryu SH, Park EY, Ryu JW, et al
    PIBF1 suppresses the ATR/CHK1 signaling pathway and promotes proliferation and motility of triple-negative breast cancer cells.
    Breast Cancer Res Treat. 2020 Jun 11. pii: 10.1007/s10549-020-05732.
    PubMed         Abstract available

  18. O'KEEFE TJ, Wallace AM
    Surveillance, Epidemiology, and End Results program underestimates breast cancer-specific mortality after ductal carcinoma in situ diagnosis.
    Breast Cancer Res Treat. 2020 Jun 11. pii: 10.1007/s10549-020-05733.

  19. AKHTAR Z, Stearns V, Cartwright P, Blackford AL, et al
    The effect of 1-day multidisciplinary clinic on breast cancer treatment.
    Breast Cancer Res Treat. 2020 Jun 8. pii: 10.1007/s10549-020-05721.
    PubMed         Abstract available

  20. BUONO G, Crispo A, Giuliano M, De Angelis C, et al
    Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study.
    Breast Cancer Res Treat. 2020 Jun 4. pii: 10.1007/s10549-020-05701.
    PubMed         Abstract available

  21. LEON-FERRE RA, Perez EA, Hillman DW, Bueno C, et al
    N083E (Alliance): long-term outcomes of patients treated in a pilot phase II study of docetaxel, carboplatin, trastuzumab, and lapatinib as adjuvant therapy for early-stage HER2-positive breast cancer.
    Breast Cancer Res Treat. 2020 Jun 5. pii: 10.1007/s10549-020-05709.
    PubMed         Abstract available

  22. RAMIREZ-EXPOSITO MJ, Martinez-Martos JM, Duenas-Rodriguez B, Navarro-Cecilia J, et al
    Neoadjuvant chemotherapy modifies serum pyrrolidone carboxypeptidase specific activity in women with breast cancer and influences circulating levels of GnRH and gonadotropins.
    Breast Cancer Res Treat. 2020 Jun 6. pii: 10.1007/s10549-020-05723.
    PubMed         Abstract available

  23. PLYM A, Johansson ALV, Bower H, Wennstig AK, et al
    Impact of chemotherapy, radiotherapy, and endocrine therapy on sick leave in women with early-stage breast cancer during a 5-year period: a population-based cohort study.
    Breast Cancer Res Treat. 2020 Jun 6. pii: 10.1007/s10549-020-05720.
    PubMed         Abstract available

  24. VIDT ME, Potochny J, Dodge D, Green M, et al
    The influence of mastectomy and reconstruction on residual upper limb function in breast cancer survivors.
    Breast Cancer Res Treat. 2020 Jun 6. pii: 10.1007/s10549-020-05717.
    PubMed         Abstract available

  25. TZIKAS AK, Nemes S, Linderholm BK
    A comparison between young and old patients with triple-negative breast cancer: biology, survival and metastatic patterns.
    Breast Cancer Res Treat. 2020 Jun 10. pii: 10.1007/s10549-020-05727.
    PubMed         Abstract available

  26. ALEIXO GFP, Shachar SS, Deal AM, Nyrop KA, et al
    The association of body composition parameters and adverse events in women receiving chemotherapy for early breast cancer.
    Breast Cancer Res Treat. 2020 Jun 9. pii: 10.1007/s10549-020-05731.
    PubMed         Abstract available

  27. ZHANG J, Lin M, Jin Y, Gu L, et al
    Cisplatin given at three divided doses for three consecutive days in metastatic breast cancer: an alternative schedule for one full dose with comparable efficacy but less CINV and hypomagnesaemia.
    Breast Cancer Res Treat. 2020 Jun 10. pii: 10.1007/s10549-020-05730.
    PubMed         Abstract available

    Breast J

  28. BROADBENT R, Ralston S, Lauder J, Howell S, et al
    Outcome of CT staging prior to neo-adjuvant chemotherapy in patients with early breast cancer.
    Breast J. 2020 Jun 10. doi: 10.1111/tbj.13931.

  29. VAN ZEELAND M, Westhoff P, Wauters C, Bult P, et al
    Omission of axillary lymph node dissection after neoadjuvant chemotherapy for clinically node-positive breast cancer: How can we select patients?
    Breast J. 2020 Jun 10. doi: 10.1111/tbj.13930.


  30. IBRAHEEM A, Olopade OI, Huo D
    Propensity score analysis of the prognostic value of genomic assays for breast cancer in diverse populations using the National Cancer Data Base.
    Cancer. 2020 Jun 10. doi: 10.1002/cncr.32956.
    PubMed         Abstract available

  31. PRINTZ C
    Women with inherited genetic mutations for breast cancer do not always receive treatment according to guidelines.
    Cancer. 2020;126:2955.

  32. DANCIU OC, Chen Z, Hoskins KF
    If you don't measure it, you can't improve it: Success and shortcomings of genomic assays in early breast cancer.
    Cancer. 2020 Jun 10. doi: 10.1002/cncr.32955.

  33. PAN K, Chlebowski RT, Mortimer JE, Gunther MJ, et al
    Insulin resistance and breast cancer incidence and mortality in postmenopausal women in the Women's Health Initiative.
    Cancer. 2020 Jun 12. doi: 10.1002/cncr.33002.
    PubMed         Abstract available

    Cancer Lett

  34. WANG B, Mao JH, Wang BY, Wang LX, et al
    Exosomal miR-1910-3p promotes proliferation, metastasis, and autophagy of breast cancer cells by targeting MTMR3 and activating the NF-kappaB signaling pathway.
    Cancer Lett. 2020 Jun 9. pii: S0304-3835(20)30300.
    PubMed         Abstract available

    Cancer Res

  35. BUNZ F
    EMT and Back Again: Visualizing the Dynamic Phenotypes of Metastasis.
    Cancer Res. 2020;80:153-155.
    PubMed         Abstract available


  36. PING J, Guo X, Ye F, Long J, et al
    Differences in gene-expression profiles in breast cancer between African and European-ancestry women.
    Carcinogenesis. 2020 Jun 8. pii: 5854539. doi: 10.1093.

    Clin Breast Cancer

  37. KOZAK MM, Horst KC, Gutkin PM, Jacobson CE, et al
    Patterns of Failure in Women Who Have Residual Nodal Disease After Neoadjuvant Chemotherapy for Breast Cancer According to Extent of Lymph Node Surgery.
    Clin Breast Cancer. 2020 May 7. pii: S1526-8209(20)30086.
    PubMed         Abstract available

    Clin Cancer Res

  38. LISCHKA A, Doberstein N, Freitag-Wolf S, Kocak A, et al
    Genome instability profiles predict disease outcome in a cohort of 4,003 breast cancer patients.
    Clin Cancer Res. 2020 Jun 10. pii: 1078-0432.CCR-20-0566.
    PubMed         Abstract available

    Eur J Cancer

  39. DUBSKY PC, Singer CF, Egle D, Wette V, et al
    The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial.
    Eur J Cancer. 2020;134:99-106.
    PubMed         Abstract available

    Exp Cell Res

  40. RASHA F, Ramalingam L, Menikdiwela K, Hernandez A, et al
    Renin angiotensin system inhibition attenuates adipocyte-breast cancer cell interactions.
    Exp Cell Res. 2020 Jun 3:112114. doi: 10.1016/j.yexcr.2020.112114.
    PubMed         Abstract available

    Int J Radiat Oncol Biol Phys

  41. Erratum to: Kirova YM, Loap P, Fourquet A. Benefit of Post Mastectomy Radiation Therapy (PMRT) in Node-Positive, HER2-Positive Patients With Breast Cancer Receiving Anti-HER2 Treatments. Int J Radiat Oncol Biol Phys 2020;106:511-513.
    Int J Radiat Oncol Biol Phys. 2020;107:606-607.

    J Clin Oncol

  42. TAKAMIZAWA S, Ishiki H, Shimoi T, Shimizu M, et al
    Neoadjuvant Cisplatin in BRCA Carriers With HER2-Negative Breast Cancer.
    J Clin Oncol. 2020 Jun 9:JCO2000789. doi: 10.1200/JCO.20.00789.

  43. SMITH TG, Troeschel AN, Castro KM, Arora NK, et al
    Perceptions of Patients With Breast and Colon Cancer of the Management of Cancer-Related Pain, Fatigue, and Emotional Distress in Community Oncology.
    J Clin Oncol. 2019 May 17:JCO1801579. doi: 10.1200/JCO.18.01579.
    PubMed         Abstract available

    J Surg Oncol

  44. JIANG Z, Yin J
    Performance evaluation of texture analysis based on kinetic parametric maps from breast DCE-MRI in classifying benign from malignant lesions.
    J Surg Oncol. 2020;121:1181-1190.
    PubMed         Abstract available

  45. HAMMOND JB, Parnall TH, Scott DW, Kosiorek HE, et al
    Gauging the efficacy of neoadjuvant endocrine therapy in breast cancer patients with known axillary disease.
    J Surg Oncol. 2020 Jun 7. doi: 10.1002/jso.26047.
    PubMed         Abstract available

    Lancet Oncol

  46. GOURD E
    Degarelix improves suppression of ovarian function.
    Lancet Oncol. 2019 Jan 11. pii: S1470-2045(19)30001.

    Nat Rev Cancer

  47. BRITT KL, Cuzick J, Phillips KA
    Key steps for effective breast cancer prevention.
    Nat Rev Cancer. 2020 Jun 11. pii: 10.1038/s41568-020-0266.
    PubMed         Abstract available


    Deep learning takes on tumours.
    Nature. 2020;580:551-553.


  49. JIANG K, Liu P, Xu H, Liang D, et al
    SASH1 suppresses triple-negative breast cancer cell invasion through YAP-ARHGAP42-actin axis.
    Oncogene. 2020 Jun 10. pii: 10.1038/s41388-020-1356.
    PubMed         Abstract available

  50. AN P, Chen F, Li Z, Ling Y, et al
    HDAC8 promotes the dissemination of breast cancer cells via AKT/GSK-3beta/Snail signals.
    Oncogene. 2020 Jun 4. pii: 10.1038/s41388-020-1337.
    PubMed         Abstract available


  51. CORSO G, Gilardi L, Girardi A, De Scalzi AM, et al
    How Useful Are Tumor Markers in Detecting Metastases with FDG-PET/CT during Breast Cancer Surveillance?
    Oncology. 2020 Jun 9:1-5. doi: 10.1159/000507707.
    PubMed         Abstract available

    PLoS One

  52. LABROSSE J, Osdoit M, Hamy AS, Coussy F, et al
    Adjuvant chemotherapy for breast cancer after preoperative chemotherapy: A propensity score matched analysis.
    PLoS One. 2020;15:e0234173.
    PubMed         Abstract available

  53. DISCALA M, Najor MS, Yung T, Morgan D, et al
    Loss of STAT6 leads to anchorage-independent growth and trastuzumab resistance in HER2+ breast cancer cells.
    PLoS One. 2020;15:e0234146.
    PubMed         Abstract available

  54. TRILLA-FUERTES L, Gamez-Pozo A, Arevalillo JM, Lopez-Vacas R, et al
    Bayesian networks established functional differences between breast cancer subtypes.
    PLoS One. 2020;15:e0234752.
    PubMed         Abstract available


  55. ULANER GA, Carrasquillo JA, Riedl CC, Yeh R, et al
    Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted (89)Zr-Pertuzumab PET/CT.
    Radiology. 2020 Jun 9:192828. doi: 10.1148/radiol.2020192828.
    PubMed         Abstract available

    Semin Oncol

  56. COOMBS DM, Djohan R, Knackstedt R, Cakmakoglu C, et al
    Advances and current concepts in reconstructive surgery for breast cancer.
    Semin Oncol. 2020 May 24. pii: S0093-7754(20)30046.
    PubMed         Abstract available

  57. PEDERSON HJ, Noss R
    Updates in hereditary breast cancer genetic testing and practical high risk breast management in gene carriers.
    Semin Oncol. 2020 May 26. pii: S0093-7754(20)30047.
    PubMed         Abstract available

    Current controversies in breast cancer screening.
    Semin Oncol. 2020 May 26. pii: S0093-7754(20)30041.
    PubMed         Abstract available

  59. SHAH C, Bauer-Nilsen K, McNulty RH, Vicini F, et al
    Novel radiation therapy approaches for breast cancer treatment.
    Semin Oncol. 2020 May 29. pii: S0093-7754(20)30042.
    PubMed         Abstract available

    Breast cancer survivorship.
    Semin Oncol. 2020 May 29. pii: S0093-7754(20)30043.
    PubMed         Abstract available

    Early stage triple negative breast cancer: Management and future directions.
    Semin Oncol. 2020 May 25. pii: S0093-7754(20)30045.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.